NZ511951A - Medicaments for treating cachexia by blocking uptake of arginine by macrophages - Google Patents

Medicaments for treating cachexia by blocking uptake of arginine by macrophages

Info

Publication number
NZ511951A
NZ511951A NZ511951A NZ51195195A NZ511951A NZ 511951 A NZ511951 A NZ 511951A NZ 511951 A NZ511951 A NZ 511951A NZ 51195195 A NZ51195195 A NZ 51195195A NZ 511951 A NZ511951 A NZ 511951A
Authority
NZ
New Zealand
Prior art keywords
macrophages
medicaments
arginine
treating cachexia
uptake
Prior art date
Application number
NZ511951A
Inventor
Marina Bianchi
Anthony Cerami
Kevin J Travey
Peter Lrich
Original Assignee
Picower Inst Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/315,170 external-priority patent/US5599984A/en
Application filed by Picower Inst Med Res filed Critical Picower Inst Med Res
Publication of NZ511951A publication Critical patent/NZ511951A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Compounds which block the uptake of arginine by macrophages or blood and blood vessels, the activity of arginase or inhibit the synthesis of urea are used in medicaments for ameliorating cahexia and the deleterious effects of nitric oxide synthesis.
NZ511951A 1994-01-21 1995-01-19 Medicaments for treating cachexia by blocking uptake of arginine by macrophages NZ511951A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18454094A 1994-01-21 1994-01-21
US08/315,170 US5599984A (en) 1994-01-21 1994-09-29 Guanylhydrazones and their use to treat inflammatory conditions
NZ281400A NZ281400A (en) 1994-01-21 1995-01-19 Aromatic amidino-hydrazone derivatives and medicaments

Publications (1)

Publication Number Publication Date
NZ511951A true NZ511951A (en) 2003-03-28

Family

ID=27353769

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ511951A NZ511951A (en) 1994-01-21 1995-01-19 Medicaments for treating cachexia by blocking uptake of arginine by macrophages

Country Status (1)

Country Link
NZ (1) NZ511951A (en)

Similar Documents

Publication Publication Date Title
MY129973A (en) Sulphonylbenzyl-substituted pyridones.
GB2303850B (en) Metalloproteinase inhibitors
MX9703621A (en) Novel amino acid derivatives with improved multi-drug resistance activity.
HUP0004421A3 (en) Urea derivatives and pharmaceutical compositions containing them, use thereof for the treatment of deseases mediated by impdh enzyme
MX9504415A (en) Aspartate protease substrate isoesters antiviral ethers.
ZA975437B (en) New pyridyl alkene and pyridyl alkine acid amides.
MX9602874A (en) Guanylhydrazones for treating inflammatory conditions.
GR3034099T3 (en) Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
TR199802421T2 (en) Substances that regulate tissue regeneration.
MY118283A (en) 6-phenyl-pyridin-2-ylamine derivatives
GB2288732B (en) Pharmaceutical compositions
ATE229533T1 (en) NITRATE SALTS AS MEDICINAL PRODUCTS
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
EP0766674A4 (en) New hiv protease inhibitors
GB9321061D0 (en) Analgestic agent and its use
MY128840A (en) Derivatives of 2-aminopyridines, their use as medicaments and pharmaceutical compositions containing them
ID24870A (en) USE OF VANADIUM COMPOUNDS, SALT AND ITS COMPLEXES THAT CAN BE ACCEPTED BY PHYSIOLOGY
GB9309387D0 (en) Nitric oxide scavengers
GB9521608D0 (en) Pharmaceutical composition
GR3031418T3 (en) Benzazole compounds for use in therapy
NZ511951A (en) Medicaments for treating cachexia by blocking uptake of arginine by macrophages
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
GR3036958T3 (en) Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and dema.
WO2001034180A3 (en) Interferon gamma for the treatment of asthma
MY131599A (en) Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity

Legal Events

Date Code Title Description
PSEA Patent sealed
S35A Application for proceedings under section 35 (restoration of lapsed patents)
RENW Renewal (renewal fees accepted)
S35R Proceedings under section 35 (restoration of lapsed patents): patent restored
S37R Proceedings under section 37 (restoration of application where complete specification not accepted): application restored
ASS Change of ownership

Owner name: CYTOKINE PHARMASCIENCES, US

Free format text: OLD OWNER(S): THE PICOWER INSTITUTE FOR MEDICAL RESEARCH